sorafenib has been researched along with Liver Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, M; Li, G; Lu, L; Qian, X; Rao, J; Wang, X; Zhang, F | 1 |
| Lohse, AW; Schramm, C; Schuch, G | 1 |
| Cho, M; Heo, J; Kang, DH; Kim, GH; Song, GA; Woo, HY; Yoon, KT | 1 |
3 other study(ies) available for sorafenib and Liver Failure
| Article | Year |
|---|---|
Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.
Topics: Antineoplastic Agents; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Sorafenib | 2013 |
Sorafenib-induced liver failure.
Topics: Adenocarcinoma, Follicular; Aged; Antineoplastic Agents; Benzenesulfonates; Female; Humans; Liver Failure; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Thyroid Neoplasms | 2008 |
Clinical course of sorafenib treatment in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Diarrhea; Disease Progression; Fatigue; Female; Hand-Foot Syndrome; Humans; Kaplan-Meier Estimate; Liver Failure; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Niacinamide; Phenylurea Compounds; Proportional Hazards Models; Pyridines; Retrospective Studies; Sorafenib; Time Factors | 2012 |